Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
33%(1 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Other(1)

Detailed Status

Completed3
Active, not recruiting1
unknown1
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%

Trials by Status

active_not_recruiting114%
unknown114%
enrolling_by_invitation114%
completed343%
not_yet_recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
enrolling_by_invitation

Long Term Follow-up Study for Subjects Administered CLBR001

NCT06882317
active_not_recruiting

Long Term Follow-up on Menkes Disease Patients

NCT04337684
not_yet_recruiting

Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leukemia

NCT07150676
completed

Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.

NCT05254873
completed

HeartMate 3 CE Mark Study Long Term Follow-up

NCT03022461
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06882317

Long Term Follow-up Study for Subjects Administered CLBR001

Enrolling By Invitation
NCT04337684

Long Term Follow-up on Menkes Disease Patients

Active Not Recruiting
NCT07150676

Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leukemia

Not Yet Recruiting
NCT05254873

Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.

Completed
NCT03022461

HeartMate 3 CE Mark Study Long Term Follow-up

Completed
NCT05256459

Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma

Unknown
NCT00234247

Prolonged Outcomes After Nitric Oxide (PrONOx)

Completed

All 7 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
7